Clopidogrel Bioequivalence Study in Healthy Subjects
NCT02185534
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
144
Enrollment
INDUSTRY
Sponsor class
Conditions
Bioequivalence, AUC, Cmax, Pharmacokinetics
Interventions
DRUG:
Clopidogrel
Sponsor
AstraZeneca